Literature DB >> 32072269

Gastrointestinal Uses of Botulinum Toxin.

Maria Cariati1, Maria Michela Chiarello1, Marco Cannistra'1, Maria Antonietta Lerose1, Giuseppe Brisinda2,3.   

Abstract

Botulinum toxin (BT), one of the most powerful inhibitors that prevents the release of acetylcholine from nerve endings, represents an alternative therapeutic approach for "spastic" disorders of the gastrointestinal tract such as achalasia, gastroparesis, sphincter of Oddi dysfunction, chronic anal fissures, and pelvic floor dyssynergia.BT has proven to be safe and this allows it to be a valid alternative in patients at high risk of invasive procedures but long-term efficacy in many disorders has not been observed, primarily due to its relatively short duration of action. Administration of BT has a low rate of adverse reactions and complications. However, not all patients respond to BT therapy, and large randomized controlled trials are lacking for many conditions commonly treated with BT.The local injection of BT in some conditions becomes a useful tool to decide to switch to more invasive therapies. Since 1980, the toxin has rapidly transformed from lethal poison to a safe therapeutic agent, with a significant impact on the quality of life.

Entities:  

Keywords:  Achalasia; Autonomic nervous system diseases; Biliary diseases; Botulinum toxin; Cholinergic nerve ending; Enteric nervous system; Esophageal diseases; Fissures; Gastric emptying; Hirschsprung; Motility; Neuromuscular agents; Obesity; Spasm; Therapeutic agents

Year:  2021        PMID: 32072269     DOI: 10.1007/164_2019_326

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  207 in total

Review 1.  Distal esophageal spasm: an update.

Authors:  Sami R Achem; Lauren B Gerson
Journal:  Curr Gastroenterol Rep       Date:  2013-09

2.  Severe constipation in Parkinson's disease relieved by botulinum toxin.

Authors:  A Albanese; G Maria; A R Bentivoglio; G Brisinda; E Cassetta; P Tonali
Journal:  Mov Disord       Date:  1997-09       Impact factor: 10.338

3.  Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study.

Authors:  Giovanni Albani; Maria Letizia Petroni; Alessandro Mauro; Antonio Liuzzi; Giovanni Lezzi; Barbara Verti; Paolo Marzullo; Laila Cattani
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

4.  Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction.

Authors:  J Alberty; M Oelerich; K Ludwig; S Hartmann; W Stoll
Journal:  Laryngoscope       Date:  2000-07       Impact factor: 3.325

5.  Effect of cricopharyngeus muscle surgery on the pharynx.

Authors:  Jacqui Allen; Cheryl J White; Rebecca Leonard; Peter C Belafsky
Journal:  Laryngoscope       Date:  2010-08       Impact factor: 3.325

6.  An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment.

Authors:  E Alfonsi; I M Merlo; M Ponzio; C Montomoli; C Tassorelli; C Biancardi; A Lozza; E Martignoni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-16       Impact factor: 10.154

7.  Transsynaptic inhibition of spinal transmission by A2 botulinum toxin.

Authors:  Norio Akaike; Min-Chul Shin; Masahito Wakita; Yasushi Torii; Tetsuhiro Harakawa; Akihiro Ginnaga; Keiko Kato; Ryuji Kaji; Shunji Kozaki
Journal:  J Physiol       Date:  2012-10-29       Impact factor: 5.182

8.  Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A.

Authors:  Alberto Albanese; Giuseppe Brisinda; Anna Rita Bentivoglio; Giorgio Maria
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

9.  Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders.

Authors:  Enrico Alfonsi; Domenico A Restivo; Giuseppe Cosentino; Roberto De Icco; Giulia Bertino; Antonio Schindler; Massimiliano Todisco; Mauro Fresia; Andrea Cortese; Paolo Prunetti; Matteo C Ramusino; Arrigo Moglia; Giorgio Sandrini; Cristina Tassorelli
Journal:  Front Pharmacol       Date:  2017-02-22       Impact factor: 5.810

10.  Intrasphincteric botulinum toxin injection in treatment of chronic idiopathic constipation in children.

Authors:  Javad Ahmadi; Saeedeh Azary; Bahar Ashjaei; Pedram Paragomi; Amin Khalifeh-Soltani
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

View more
  3 in total

Review 1.  Evaluating the Non-conventional Achalasia Treatment Modalities.

Authors:  Francisco Tustumi
Journal:  Front Med (Lausanne)       Date:  2022-06-24

2.  Botulinum toxin injection for the treatment of chronic anal fissure: uni- and multivariate analysis of the factors that promote healing.

Authors:  Giuseppe Brisinda; Maria Michela Chiarello; Anna Crocco; Anna Rita Bentivoglio; Maria Cariati; Serafino Vanella
Journal:  Int J Colorectal Dis       Date:  2022-02-11       Impact factor: 2.571

3.  Comparison of safety and efficacy of intragastric botulinum toxin-A versus gastric balloon.

Authors:  Raed M Tayyem; Haitham G Qandeel; Hamzeh I Al-Balas; Farah R Tayyem; Jehad Z Fataftah; Mahmoud I Al-Balas
Journal:  Saudi J Gastroenterol       Date:  2022 Jul-Aug       Impact factor: 3.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.